A CBD-rich cannabis extract inhibited human T cell proliferation and function without killing the cells, working through CB2 and TRPV1 receptors.
Researchers interested in CBD immunology and potential anti-inflammatory applications.
Immunosuppressive effects mostly due to CBD, mediated by CB2 and TRPV1
What the researchers found
A cannabis extract with 14% CBD and 0.2% THC inhibited T lymphocyte proliferation in a dose-dependent manner without causing cell death. The extract suppressed T cell activation markers (CD25), degranulation, and production of IL-2 and IFN-gamma. Effects were mediated through CB2 and TRPV1 receptors and AP-1/NFAT transcription pathways.
Why it matters
Understanding how cannabis extracts modulate the immune system could inform therapeutic approaches for autoimmune and inflammatory conditions.
The numbers in context
14% CBD, 0.2% THC concentration in the extract. Effects were dose-dependent and reversible with CB2 antagonist (SR144528) and TRPV1 antagonist (A78416B).
How the study worked
In vitro study using primary human lymphocytes and Jurkat reporter cell lines. Tested a high-CBD, low-THC cannabis extract against pure CBD, measuring proliferation, activation markers, cytokine production, and receptor involvement.
What this study cannot tell us
In vitro study using isolated cells. Immune system behavior in living organisms involves complex interactions not captured in cell culture. Effective concentrations may not be achievable in the body.
How to read the evidence
Well-designed in vitro study with mechanism identification, but no in vivo confirmation.
When this study was published
Published in 2022.
The bigger picture
The finding that the extract's immunosuppressive effects were mostly attributable to CBD suggests CBD-dominant preparations could have therapeutic potential for conditions involving overactive T cell responses.
Questions still open
- Would these immunosuppressive effects translate to reduced inflammation in living organisms? Could CBD-rich extracts serve as adjunct therapy for autoimmune conditions?
Common questions
Did the cannabis extract damage the immune cells?
Was the effect from CBD or other compounds in the extract?
Read the original research
Immunosuppressive activity of non-psychoactive Cannabis sativa L. extract on the function of human T lymphocytes.
International immunopharmacology, 103, 108448
Citation
Devi, Seema; Zimmermann-Klemd, Amy M; Fiebich, Bernd L; Heinrich, Michael; Gründemann, Carsten; Steinberger, Peter; Kowarschik, Stefanie; Huber, Roman. (2022). Immunosuppressive activity of non-psychoactive Cannabis sativa L. extract on the function of human T lymphocytes.. International immunopharmacology, 103, 108448. https://doi.org/10.1016/j.intimp.2021.108448
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk